Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

Andrews, C. N., Rehak, R., Woo, M., Walker, I., Ma, C., Forbes, N., Rittenbach, K., Hathaway, J., Wilsack, L., Liu, A., Nasser, Y., & Sharkey, K. A. (2022). Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence. Alimentary Pharmacology & Therapeutics, 56(11–12), 1532–1542. Portico. https://doi.org/10.1111/apt.17265
Authors:
Christopher N Andrews
Renata Rehak
Matthew Woo
Ian Walker
Christopher Ma
Nauzer Forbes
Katherine Rittenbach
Joshua Hathaway
Lynn Wilsack
Andy Liu
Yasmin Nasser
Keith A Sharkey
Affiliated Authors:
Andy Liu
Subjects:
Cannabinoids (MeSH)
COVID-19 (MeSH)
Publication Type:
Article
Unique ID:
10.1111/apt.17265
PMID:
Publication Date:
Data Source:
PubMed

Record Created: